Our Thanks to Reviewers in 2010

Article

At Consultant, our goal is to provide the practical, authoritative information you need to best serve your patients. That is why we "pre-test" article ideas (before we invite articles on those topics) to be sure they are of real interest to you and your colleagues. It is also why we take great care in checking facts, creating useful tables and figures, and choosing illustrations and photographs to enhance teaching messages.

At Consultant, our goal is to provide the practical, authoritative information you need to best serve your patients. That is why we "pre-test" article ideas (before we invite articles on those topics) to be sure they are of real interest to you and your colleagues. It is also why we take great care in checking facts, creating useful tables and figures, and choosing illustrations and photographs to enhance teaching messages.

And it is why all articles we publish must survive peer review not only by the distinguished leaders in primary care who make up our editorial board but also by several specialists and primary care physicians culled from Consultant readers. We ask reviewers to consider whether the discussion is accurate, balanced, complete, and timely; the drug regimens are reasonable; controversies are fairly outlined; the clinical advice is clear; and the recommended diagnostic and therapeutic measures are widely available in the community.

The questions these reviewers pose help the authors and staff keep Consultant squarely focused on your educational needs.

In this, the last issue of our 50th year of publication, we want to extend our thanks to the following reviewers who appraised at least one manuscript for us in 2010.

Navin M. Amin, MD Sandra L. Argenio, MD Richard Balon, MD Kirk Barber, MD J. David Beckham, MD Gerald Bernstein, MD Henry R. Black, MD Robert P. Blereau, MD William J. Brady, MD Charles S. Bryan, MD R. Michael Buckley, MD Lee S. Caplan, MD, PhD Roberto Cardarelli, DO, MPH Mercedes R. Carnethon, PhD Michael B. Chancellor, MD Rachmel Cherner, MD John F. Connolly, MD Mary E. Costanza, MD David Effron, MD S. Ather Enam, MD, PhD Richard G. Farmer, MD Faith T. Fitzgerald, MD Peter Frank, DO David R. Garr, MD Paul Gleich, MD Ladan Golestaneh, MD Caron M. Grin, MD Michael E. Hagensee, MD, PhD Gregory S. Harmon, MD Richard Harrigan, MD Warren A. Heffron, MD Jorge L. Herrera, MD Russell J. Hopp, DO Grace Brooke Huffman, MD Ben Huneycutt, MD Steve Iliffe, FRCGP Jonathan S. Ilowite, MD Mohit Jain, MD Kenar D. Jhaveri, MD Melissa Jones, PharmD Deepak M. Kamat, MD, PhD David L. Kaplan, MD Lawrence I. Kaplan, MD Jeffrey T. Kirchner, MD Harvey M. Kramer, MD Robert E. Leach, MD Edgar V. Lerma, MD Alexander K. C. Leung, MD Joseph A. Lieberman III, MD, MPH Richard Y. McConnell, MD Eugene Mochan, PhD, DO
Prashanth R. Mopala, MD John Mosby, MD Dale P. Murphy, MD Anita Nelson, MD David B. Nash, MD, MBA David T. Nash, MD Morris Papernik, MD Jacqueline G. Parthemore, MD Thomas L. Petty, MD Michael F. Picco, MD, PhD Susan M. Pollart, MD, MS D. Brady Pregerson, MD L. Michael Prisant, MD Robert E. Rakel, MD Sujatha Ramesh, MD Robert E. Reisman, MD Wayne Reynolds, DO Dale Rice, MD Diana Rinkevich, MD Robert J. Rogers, MD, FACP Ted Rosen, MD Marti Jill Rothe, MD Ronald N. Rubin, MD Gary E. Ruoff, MD Gregory W. Rutecki, MD Joseph D. Schmidt, MD Robert T. Segraves, MD, PhD Timothy H. Self, PharmD Edward J. Shahady, MD Leonid Skorin Jr, DO Clark Smith, MD Christopher Snell, PhD Andr N. Sofair, MD Todd P. Stitik, MD Michael B. Strauss, MD Stephen B. Sulavik, MD Nicole Touchet, MD Edward L. Trimble, MD Donald G. Vidt, MD Edward M. Weaver, MD, MPH Michael H. Weisman, MD Stuart Weiss, MD Herbert White, MD, MPH Russell D. White, MD James T. Willerson, MD Robert J. Wolfson, MD William Yaakob, MD Barbara P. Yawn, MD Durgamani K. Yellumahanthi, MD Richard J. Zimmer, DO
Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea with Obesity

FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea with Obesity

Patient Care Editorial Staff
December 20th 2024
Article

This marks the second indication for tirzepatide in just more than a year, following its November 2023 approval for adults with obesity or overweight and weight-related medical problems.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Crinecerfont for Congenital Adrenal Hyperplasia Now Commercially Available, Neurocrine Biosciences Announces / image credit courtesy of Neurocrine Biosciences

Crinecerfont for Congenital Adrenal Hyperplasia Now Commercially Available, Neurocrine Biosciences Announces

Grace Halsey
December 20th 2024
Article

The first in class CRF-1 receptor antagonist allows people with CAH to reduce glucocorticoid doses while androgen levels are maintained or improved.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Sydney Jennings
October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Atogepant Improves QoL in Chronic, Episodic Migraine: Daily Dose / image credit: ©New Africa/AdobeStock

Atogepant Improves QoL in Chronic, Episodic Migraine: Daily Dose

Sydney Jennings
December 20th 2024
Article

Your daily dose of the clinical news you may have missed.

Women at higher risk for PTSD than men, according to large twin-sibling study / image credit ©Microgen/stock.adobe.com

Women are at Higher Genetic Risk for PTSD than Men, According to Large Twin-Sibling Study

Grace Halsey
December 19th 2024
Article

In the largest twin-sibling study to date of the inherited biological risk of PTSD, researchers found additive genetic and unique environmental effects contributed to the disorder.

© 2024 MJH Life Sciences

All rights reserved.